Exodus Point Capital Management, LP Stoke Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$12.56 - $22.53 $197,217 - $353,766
15,702 New
15,702 $202,000
Q1 2021

May 17, 2021
SELL
$36.08 - $69.81 $178,379 - $345,140
-4,944 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$33.62 - $61.93 $166,217 - $306,181
4,944 New
4,944 $306,000

Others Institutions Holding STOK

# of Institutions
125
Shares Held
57.6M
Call Options Held
9.3K
Put Options Held
35.2K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $367M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email